Strong effect of mogamulizumab on splenic residual disease of adult T cell leukemia/lymphoma

Ann Hematol. 2014 Apr;93(4):719-20. doi: 10.1007/s00277-013-1874-2. Epub 2013 Aug 15.

Authors

Daisuke Ohgiya¹, Shinichiro Machida, Akihumi Ichiki, Jun Amaki, Yasuyuki Aoyama, Hidetsugu Kawai, Mitsuki Miyamoto, Hiromichi Murayama, Makoto Onizuka, Kiyoshi Ando

Affiliation

¹ Department of Hematology and Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan, [email protected].

PMID: 23949316
DOI: 10.1007/s00277-013-1874-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Fatal Outcome
Female
Humans
Leukemia-Lymphoma, Adult T-Cell / diagnostic imaging*
Leukemia-Lymphoma, Adult T-Cell / drug therapy*
Middle Aged
Neoplasm, Residual
Radionuclide Imaging
Spleen / diagnostic imaging*
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
mogamulizumab